Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motoko Yanagita

Showing results (1-10 of 304) with videos related to

Pageof 31
Sort By:
Biofactors (Oxford, England)|May 19, 2009
BMP modulators regulate the function of BMP during body patterning and disease progressionMotoko Yanagita
Current Opinion in Investigational Drugs (London, England : 2000)|February 24, 2010
Antagonists of bone morphogenetic proteins in kidney diseaseMotoko Yanagita
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 30, 2007
[Kidney diseases and bone morphogenetic protein]Motoko Yanagita
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 6, 2007
Balance between bone morphogenetic proteins and their antagonists in kidney injuryMotoko Yanagita
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 2, 2012
Inhibitors/antagonists of TGF-β system in kidney fibrosisMotoko Yanagita
Nihon Jinzo Gakkai Shi|March 7, 2013
[Basic research advances 2012]Motoko Yanagita
Cytokine & Growth Factor Reviews|June 14, 2005
BMP antagonists: their roles in development and involvement in pathophysiologyMotoko Yanagita
Current Opinion in Nephrology and Hypertension|June 17, 2004
The role of the vitamin K-dependent growth factor Gas6 in glomerular pathophysiologyMotoko Yanagita
Clinical and Experimental Nephrology|December 25, 2004
Gas6, warfarin, and kidney diseasesMotoko Yanagita
Kidney International|November 22, 2021
Unexpected cause of vemurafenib-induced nephrotoxicity: ferrochelataseRyo Yamada, Motoko Yanagita
Pageof 31

Showing results (1-10 of 304) with videos related to

Sort By:
Pageof 31
Biofactors (Oxford, England)|May 19, 2009
BMP modulators regulate the function of BMP during body patterning and disease progressionMotoko Yanagita
Current Opinion in Investigational Drugs (London, England : 2000)|February 24, 2010
Antagonists of bone morphogenetic proteins in kidney diseaseMotoko Yanagita
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 30, 2007
[Kidney diseases and bone morphogenetic protein]Motoko Yanagita
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 6, 2007
Balance between bone morphogenetic proteins and their antagonists in kidney injuryMotoko Yanagita
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 2, 2012
Inhibitors/antagonists of TGF-β system in kidney fibrosisMotoko Yanagita
Nihon Jinzo Gakkai Shi|March 7, 2013
[Basic research advances 2012]Motoko Yanagita
Cytokine & Growth Factor Reviews|June 14, 2005
BMP antagonists: their roles in development and involvement in pathophysiologyMotoko Yanagita
Current Opinion in Nephrology and Hypertension|June 17, 2004
The role of the vitamin K-dependent growth factor Gas6 in glomerular pathophysiologyMotoko Yanagita
Clinical and Experimental Nephrology|December 25, 2004
Gas6, warfarin, and kidney diseasesMotoko Yanagita
Kidney International|November 22, 2021
Unexpected cause of vemurafenib-induced nephrotoxicity: ferrochelataseRyo Yamada, Motoko Yanagita
Pageof 31